Bridgeway Capital Management’s ACELYRIN SLRN Stock Holding History

Bridgeway Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-140,900	Closed	-$348K	–	1257
2025 Q1	$348K	Buy	+140,900	New	+$335K	0.01%	811

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgeway Capital Management's SLRN Position: Q2 2025 in Review

Bridgeway Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 140,900 shares — an estimated $348K sold.

Bridgeway Capital Management first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $348K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Bridgeway Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Bridgeway Capital Management sold 140,900 ACELYRIN shares in Q2 2025, an estimated $348K.
Bridgeway Capital Management first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
Bridgeway Capital Management's ACELYRIN position peaked at $348K in Q1 2025.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.